US approves first Herceptin biosimilar

4th December 2017 Uncategorised 0

Mylan and Biocon’s Ogivri is the first biosimilar of Herceptin to win US approval, for certain breast cancer and metastatic stomach cancers.

More: US approves first Herceptin biosimilar
Source: News